The objective of this study was (1) To compare the effects of different frequencies of prostate specific antigen (PSA) surveillance after prostate cancer treatment on health outcomes; (2) To compare the effects of different post-treatment PSA surveillance frequencies on patient-reported anxiety and quality of life.

Project page: Comparing the Effects of How Often Men Have PSA Testing in the First Year after Prostate Cancer Treatment
Principal Investigator: Ronald C. Chen, MD, MPH
Organization: The Alliance for Clinical Trials in Oncology Foundation
Original project title: Optimizing the Effectiveness of Routine Post-Treatment Surveillance in Prostate Cancer Survivors
HSRProj ID: 20162120
ClinicalTrials.gov ID: NCT02957357

To cite this document, please use: Katz AJ, Basak R, Chen RC. (2020). Comparing the Effects of How Often Men Have PSA Testing in the First Year after Prostate Cancer Treatment. Patient-Centered Outcomes Research Institute (PCORI).https://doi.org/10.25302/05.2020/CER.150329220

Tags

Resource Type

What's Happening at PCORI?

The Patient-Centered Outcomes Research Institute sends weekly emails highlighting results of our funded studies, newly funded research and engagement awards, opportunities to apply for funding, stakeholder workshops, and original feature stories about our funded projects.

Sign Up for Updates

Image

Hand pointing to email icon